Risk Management for Biotech Companies in Clinical Trials
When we discuss risk, it’s often focused on the negative threats where there is a need to mitigate or avoid threats to the project that could impact timelines, deliverables or quality. One can look...Preparation for Biotech Testing or Clinical Trials
Your clinical trial may involve samples from multiple sites to be tested by multiple laboratories. The data that flows from those tests may travel to multiple end users as well. Proper planning of...
Barry Jones, Ph.D.
Bridging the Ligand Binding Assays and LC-MS Disciplines for Hybrid Assays
Assessing the pharmacokinetics of biologics presents several analytical challenges, from the use of critical reagents and assay sensitivity requirements to regulatory and throughput considerations....
Patrick Hurban, Ph.D.
Genomic Assays for Clinical Development
Author:Patrick Hurban, Ph.D., Global Head, Senior Director, Translational Genomics, Q2 Solutions Choosing the right genomic assays from a wealth of potential options stands as one of the most...